• 国家药监局综合司 国家卫生健康委办公厅
  • 国家药监局综合司 国家卫生健康委办公厅

[title missed]

Corresponding author: yangyuping, 978288587@qq.com
DOI: 10.12201/bmr.202611.00008
Statement: This article is a preprint and has not been peer-reviewed. It reports new research that has yet to be evaluated and so should not be used to guide clinical practice.
  •  

    Abstract: Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic upper airway disease characterized by persistent sinonasal mucosal inflammation and nasal polyp formation, which significantly reduces patients’ quality of life and increases healthcare burden. The core of its pathology lies in the dominant role of type 2 inflammation (T2 inflammation): approximately 96% of patients’ nasal polyp tissues exhibit T2 features. After injury to the nasal and sinonasal epithelium, epithelial-derived alarmins (TSLP, IL-33, and IL-25) are released. Through their respective unique receptor-signaling pathways, they activate ILC2s and Th2 cells, initiating and amplifying type 2 immune responses, and ultimately driving eosinophil infiltration, increased mucus secretion, tissue remodeling, and polyp growth. Studies have shown that epithelial-derived alarmins are significantly upregulated in nasal polyp tissues, and their expression levels correlate with disease severity and the degree of eosinophil infiltration. Epithelial-derived alarmins play an important role in regulating inflammatory responses; however, their correlation with eosinophil-infiltrated nasal polyps remains unclear. Exploring and identifying clinical indicators associated with eosinophil-infiltrated nasal polyps may provide new ideas for the diagnosis and treatment of nasal polyps.

    Key words: chronic rhinosinusitis with nasal polyps; alarmins; TSLP; IL-33; IL-25

    Submit time: 6 November 2026

    Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
  • 图表

  • LIU Ruyang, ZHANG Guopeng, SUN Hongwei, FANG Zhensheng. Research progress of IL-37 in respiratory diseases. 2025. doi: 10.12201/bmr.202501.00038

    Fei Danting. Clinical value of systemic immune-inflammation index combined with IL-4 and IL-8 in predicting acute lung injury after traumatic brain injury. 2026. doi: 10.12201/bmr.202609.00014

    Yao Jin. The expression of IL-16 in immune and tumor related diseases and its anti-tumor application research. 2026. doi: 10.12201/bmr.202603.00011

    leihouxing, zhangxiaoqin, zhangyixing. Clinical study on the treatment of chronic sinusitis in children by nasal irrigation with Melastoma dodecandrum Lour. 2025. doi: 10.12201/bmr.202504.00021

    HUO Jie, HANG Feifei, XU Jing, GUAN Zheng. Value of serum IgE, LDH, and IL-18 in the early identification of refractory mycoplasma pneumoniae pneumonia in children. 2026. doi: 10.12201/bmr.202606.00009

    zhanglei. Effect of targeted temperature management on cerebrospinal fluid IL-6 in patients with severe craniocerebral injury. 2025. doi: 10.12201/bmr.202501.00079

    The diagnostic value of neutrophil CD64 index, CRP, IL-6, and PCT levels in viral and bacterial respiratory infections. 2024. doi: 10.12201/bmr.202412.00064

    Zhanglin, Houyanhong, Lixianghui, Houhui, Zhangjing, Wukai. Preparation of a novel recombinant vaccinia virus carrying CXCL9 and IL-7 genes and its anti-tumor effect in vitro. 2026. doi: 10.12201/bmr.202607.00010

    WUJiang. Research Progress on the Correlation between Triglyceride-Glucose Index and Metabolic Dysfunction-Associated Fatty Liver Disease as Well as Colorectal Polyps. 2026. doi: 10.12201/bmr.202608.00024

    任益龙, Jiang Chunming. A Mendelian randomization study on the causal relationship between 25-hydroxyvitamin D and tic disorder. 2025. doi: 10.12201/bmr.202507.00007

  • ID Submit time Number Download
    1 2026-10-12

    10.12201/bmr.202611.00008V1

    Download
  • Public  Anonymous  To author only

Get Citation

yangyuping. [title missed]. 2026. biomedRxiv.202611.00008

Article Metrics

  • Read: 118
  • Download: 0
  • Comment: 0

Email This Article

User name:
Email:*请输入正确邮箱
Code:*验证码错误